-
公开(公告)号：CA2810842A1
公开(公告)日：2012-03-15
申请号：CA2810842
申请日：2011-09-09
Applicant: MICELL TECHNOLOGIES INC
Inventor： MCCLAIN JAMES B , CARLYLE WENDA C , TAYLOR CHARLES DOUGLAS
Abstract: Provided is a drug delivery composition comprising at least one polymer and at least one active agent; wherein the active agent is present in crystalline form on at least one region of an outer surface of the composition and wherein active agent surface content is adjusted to provide a selected active agent release profile.
-
公开(公告)号：CA2997668C
公开(公告)日：2021-06-01
申请号：CA2997668
申请日：2016-09-09
Applicant: MICELL TECHNOLOGIES INC
Inventor： CARLYLE WENDA C
Abstract: Drug delivery systems are disclosed which include a drug in dry powder form and a biodegradable or metabolizable carrier having an average particle size of less than about 1 mm for delivery of the drug to a particular location in the body and for providing for the timed elution of the drug at that location, preferably by exhibiting a linear drug elution profile for a sustained drug release period of at least 30 days. Methods for manufacturing these drug delivery systems are also disclosed.
-
Patent Agency Ranking
公开(公告)号：CA2810842C
公开(公告)日：2018-06-26
申请号：CA2810842
申请日：2011-09-09
Applicant: MICELL TECHNOLOGIES INC
Inventor： MCCLAIN JAMES B , CARLYLE WENDA C , TAYLOR CHARLES DOUGLAS
Abstract: Provided is a drug delivery composition comprising at least one polymer and at least one active agent; wherein the active agent is present in crystalline form on at least one region of an outer surface of the composition and wherein active agent surface content is adjusted to provide a selected active agent release profile.
-
公开(公告)号：HK1251180A1
公开(公告)日：2019-01-25
申请号：HK18110756
申请日：2018-08-21
Applicant: MICELL TECHNOLOGIES INC
Inventor： CARLYLE WENDA C
IPC: A61K20060101
-
公开(公告)号：CA2997668A1
公开(公告)日：2017-03-16
申请号：CA2997668
申请日：2016-09-09
Applicant: MICELL TECHNOLOGIES INC
Inventor： CARLYLE WENDA C
Abstract: Drug delivery systems are disclosed which include a drug in dry powder form and a biodegradable or metabolizable carrier having an average particle size of less than about 1 mm for delivery of the drug to a particular location in the body and for providing for the timed elution of the drug at that location, preferably by exhibiting a linear drug elution profile for a sustained drug release period of at least 30 days. Methods for manufacturing these drug delivery systems are also disclosed.
-
公开(公告)号：AU2016319782A1
公开(公告)日：2018-04-05
申请号：AU2016319782
申请日：2016-09-09
Applicant: MICELL TECHNOLOGIES INC
Inventor： CARLYLE WENDA C
Abstract: Drug delivery systems are disclosed which include a drug in dry powder form and a biodegradable or metabolizable carrier having an average particle size of less than about 1 mm for delivery of the drug to a particular location in the body and for providing for the timed elution of the drug at that location, preferably by exhibiting a linear drug elution profile for a sustained drug release period of at least 30 days. Methods for manufacturing these drug delivery systems are also disclosed.
-
公开(公告)号：WO2012034079A3
公开(公告)日：2012-05-18
申请号：PCT/US2011051092
申请日：2011-09-09
Applicant: MICELL TECHNOLOGIES INC , MCCLAIN JAMES B , CARLYLE WENDA C , TAYLOR CHARLES DOUGLAS
Inventor： MCCLAIN JAMES B , CARLYLE WENDA C , TAYLOR CHARLES DOUGLAS
IPC: A61K9/00
CPC classification number: A61K9/7007 , A61K9/0019 , A61K9/0021 , A61K31/436 , A61K47/34
Abstract: Provided is a drug delivery composition comprising at least one polymer and at least one active agent; wherein the active agent is present in crystalline form on at least one region of an outer surface of the composition and wherein active agent surface content is adjusted to provide a selected active agent release profile.
Abstract translation: 提供了包含至少一种聚合物和至少一种活性剂的药物递送组合物; 其中所述活性剂以结晶形式存在于所述组合物的外表面的至少一个区域上，并且其中调节活性剂表面含量以提供选定的活性剂释放曲线。
-
-
-
-
-
-
Search Results
7
records
(took 0.025 seconds)
